Straumann Holding AG

  • WKN: 914326
  • ISIN: CH1175448666
  • Land: Schweiz

Nachricht vom 12.08.2004 | 06:37

Straumann lifts first-half sales by 33% to CHF 217 million (Part 3 of 3)

Corporate-news announcement processed and sent by DGAP.
The sender is solely responsible for the contents of this announcement.

----- Download the full media release, including additional financial tables: Straumann lifts first-half sales by 33% to CHF 217 million (Part 3 of 3) Disclaimer This interim report contains certain "forward-looking statements", which can be identified by the use of terminology such as "scheduled to", "will", "expected to", "forecast", "expectation", or similar wording. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Group to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group's products, the potential for the Group's products to become obsolete, the Group's ability to defend its intellectual property, the Group's ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group's ability to generate revenues and profitability, and the Group's ability to realize its expansion projects in Andover and Basel in a timely manner. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this report. Straumann is providing the information in this report as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise. Waldenburg, 12 August 2004 Contacts: Gilbert Achermann, Chief Executive Officer (+41) 061 965 1111 Martin Gertsch, Chief Financial Officer (+41) 061 965 1111 Mark Hill, Corporate Communication (+41) 061 965 1321 About Straumann Headquartered in Waldenburg, Switzerland, Straumann is a global leader in oral implantology and tissue regeneration. In collaboration with the International Team for Implantology (ITI), leading clinics, research institutes and universities, the Group researches, develops, produces and distributes implants, instruments and tissue regeneration products for use in tooth replacement solutions or to prevent tooth loss. Straumann also provides training and services to the dental profession worldwide. Straumann's implants and instruments are manufactured in Switzerland, whilst its dental tissue regeneration products are produced in Sweden. With affiliates in 14 countries and distributors in 35, Straumann employs more than 1000 people worldwide. In 2003, the Group generated sales of CHF 344 million and a net income of CHF 80 million. Straumann Holding AG, Hauptstrasse 26, 4427 Waldenburg, Switzerland Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01 e-mail: or Homepage: End part 3 of 3 end of message, (c)DGAP 12.08.2004
----- WKN: 914326; ISIN: CH0012280076; Index: Listed: Freiverkehr in Berlin-Bremen, Frankfurt, München und Stuttgart; SWX Swiss Exchange 120637 Aug 04

Events im Fokus

Termine 2022

1./2. Juni 2022: Fachkonferenz Immobilien & Software | IT

13./14. Juli 2022: Fachkonferenz Beteiligungsgesellschaften & Consumer/Leisure

12./13. Oktober 2022: Fachkonferenz Finanzdienstleistungen/Technologie

Aktueller Webcast

Kinarus Therapeutics Holding AG

Replay KOL Webcast: Christian Pruente on wAMD and KIN001

27. Juni 2022

Aktuelle Research-Studie

FORTEC Elektronik Aktiengesellschaft

Original-Research: FORTEC Elektronik AG (von Montega AG): Kaufen

01. Juli 2022